KMDA Stock Analysis: Buy, Sell, or Hold?
KMDA - Kamada Ltd
$7.23
0.09 (1.26%)
▲
5d:
+3.43%
30d:
-3.6%
90d:
-11.94%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
8d
Get Alerted When KMDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: KMDA trading at deep discount. Market pricing in -7.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: KMDA trading at deep discount. Market pricing in -7.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.56
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.90
33.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: KMDA is currently trading at $7.23, which is considered fair relative to its 30-day fair value range of $7.02 to $7.35. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.6) compared to its historical average (14.7). Remarkably, the market is currently pricing in an annual earnings decline of 7.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, KMDA is in a strong downtrend. The price is approaching resistance at $7.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: KMDA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+82.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, KMDA is in a strong downtrend. The price is approaching resistance at $7.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: KMDA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+82.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.02 -
$7.35
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 82.1% below Wall St target ($13.00)
Trading Range Analysis
30-Day Trading Range
$7.02 -
$7.35
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$6.89
Resistance Level
$7.31
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.64
Wall Street Target
$13.00
(+82.1%)
Revenue Growth (YoY)
2.8%
Profit Margin
11.2%
Valuation Discount vs History
-7.5% cheaper
PE vs Historical
11.6 vs 14.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.5%
(market-implied from PE analysis)
1-Year Target
$6.60
(-8%)
2-Year Target
$6.11
(-14%)
3-Year Target
$5.65
(-21%)
3-Yr Target (if PE normalizes)
(PE: 12→15)
$7.14
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 43.5%)
$37.54
(+426%)
Base:
(SPY PE: 11.6, Growth: 43.5%)
$21.08
(+195%)
Bear:
(PE: 9.9, Growth: 43.5%)
$17.92
(+151%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 20.29 | Current EPS (TTM): $0.35
Bull Case
$13.69
(+92%)
Analyst growth 75.2%, PE expands to 22.3
Base Case
$12.44
(+74%)
Market implied 75.2%, PE stable at 20.3
Bear Case
$4.83
(-32%)
Severe decline -20.0%, PE contracts to 17.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.6 to 14.7
Stabilization Target:
$9.02
(+26.3%)
PE Expansion Potential:
+26.3%
Share & Embed Analysis
Last updated: August 03, 2026 4:58 PM ET
Data refreshes hourly during market hours. Next update: 5:58 PM
Data refreshes hourly during market hours. Next update: 5:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KMDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
